The DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index.
Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials
Open accessAbstract
Objective To describe the effects of treatment for 1 year with ranibizumab or bevacizumab on macular morphology and the association of macular morphology with visual acuity (VA) in eyes with neovascular age-related macular degeneration (AMD).Design Prospective cohort study within a randomized clinical trial.Participants Participants in the Comparison of Age-related Macular Degeneration Treatments Trials.Methods Participants were assigned randomly to treatment with ranibizumab or bevacizumab on a monthly or as-needed schedule. Optical coherence tomography (OCT), fluorescein angiography (FA), color fundus photography (FP), and VA testing were performed periodically throughout 52 weeks. Masked readers graded images. General linear models were applied to evaluate effects of time and treatment on outcomes.Main outcome measures Fluid type and location and thickness by OCT, size, and lesion composition on FP, FA, and VA.Results Intraretinal fluid (IRF), subretinal fluid (SRF), subretinal pigment epithelium fluid, and retinal, subretinal, and subretinal tissue complex thickness decreased in all treatment groups. A higher proportion of eyes treated monthly with ranibizumab had fluid resolution at 4 weeks, and the difference persisted through 52 weeks. At 52 weeks, there was little association between the presence of fluid of any type (without regard to fluid location) and the mean VA. However, at all time points, eyes with residual IRF, especially foveal IRF, had worse mean VA (9 letters) than those without IRF. Eyes with abnormally thin (<120 μm) or thick (>212 μm) retinas had worse VA than those with normal thickness (120-212 μm). At week 52, eyes with larger neovascular lesions or with foveal scar had worse VA than eyes without these features.Conclusions Anti-vascular endothelial growth factor (VEGF) therapy reduced lesion activity and improved VA in all treatment groups. At all time points, eyes with residual IRF had worse VA than those without. Eyes with abnormally thin or thick retinas, residual large lesions, and scar also had worse VA. Monthly ranibizumab dosing yielded more eyes with no fluid and an abnormally thin retina, although the long-term significance is unknown. These results have important treatment implications in eyes undergoing anti-VEGF therapy for neovascular AMD.Financial disclosure(s) Proprietary or commercial disclosure may be found after the references.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Subretinal and retinal scarring are associated with profound vision loss and are natural outcomes of neovascular age-related macular degeneration (nvAMD).1–4”
From Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials (2014) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The response to anti-VEGF therapy have been found to be dependent on a variety of factors including patient's age, lesion characteristics, lesion duration, baseline visual acuity (VA) and the presence of particular genotype risk alleles.”
From Defining response to anti-VEGF therapies in neovascular AMD (2015) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In a previous CATT report, we described a strong association between decreased visual acuity at the end of 1 year and the presence of intraretinal fluid but not subretinal or sub-RPE fluid on OCT.1”
From Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials (2014) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Similarly, the morphological outcomes may also vary from complete resolution of the lesion to a fibrovascular scar despite presumed adequate monitoring of the disease.14”
From Defining response to anti-VEGF therapies in neovascular AMD (2015) · cites this paper as [14]
In the citing paper
“We previously reported that retinal thinning to <120 microns was associated with worse VA outcomes at 1 and 2 years.36,37”
From Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration (2016) · cites this paper as [36]
In the citing paper
“On a cross-sectional basis, the presence of intraretinal fluid is associated with worse visual acuity during anti-VEGF treatment while the presence of subretinal fluid is associated with better visual acuity.36–38”
From Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration (2016) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robust Locally Weighted Regression and Smoothing Scatterplots
Cleveland, W. S. (1979) · Journal of the American Statistical Association · doi:10.1080/01621459.1979.10481038 · Cited by 11,594
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Martin, D. F., Maguire, M. G., Fine, S. L., Ying, G.-S., Jaffe, G. J., Grunwald, J. E., Toth, C., Redford, M., & Ferris, F. L. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.03.053 · Cited by 1,715
Self-citationA computerized method of visual acuity testing
Beck, R. W., Moke, P. S., Turpin, A. H., Ferris, F. L., SanGiovanni, J. P., Johnson, C. A., Birch, E. E., Chandler, D. L., Cox, T. A., Blair, R. C., et al. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01825-1 · Cited by 613
Normal Macular Thickness Measurements in Healthy Eyes Using Stratus Optical Coherence Tomography
Chan, A. Y. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.2.193 · Cited by 425
ANCHOR STUDY GROUP. RANIBIZUMAB VERSUS VERTEPORFIN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Brown, D., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., & Kim, R. Y. (2006) · Cited by 382
Ying, G.-S., Huang, J., Maguire, M. G., Jaffe, G. J., Grunwald, J. E., Toth, C., Daniel, E., Klein, M., Pieramici, D., Wells, J., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.07.042 · Cited by 305
Self-citationKaiser, P. K., Blodi, B. A., Shapiro, H., & Acharya, N. R. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.04.030 · Cited by 219
Flagged first, then by citations
1 of the 15 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 292
Ehlers, J. P., Clark, J., Uchida, A., Figueiredo, N., Babiuch, A. S., Talcott, K. E., Lunasco, L. M., Le, T. K., Meng, X., Hu, M., et al. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.3.29 · Cited by 24
Haddad, W. M., Minous, F. L., Legeai, J., & Souied, E. H. (2016) · Retina · doi:10.1097/iae.0000000000001282 · Cited by 24
Giancipoli, E., Pinna, A., Boscia, F., Zasa, G., Sotgiu, G., Dore, S., & Ricci, G. D. (2018) · Journal of Ophthalmology · doi:10.1155/2018/5612342 · Cited by 23
Core, J. Q., Pistilli, M., Hua, P., Daniel, E., Grunwald, J. E., Toth, C. A., Jaffe, G. J., Martin, D. F., Maguire, M. G., Ying, G., et al. (2022) · Ophthalmology Retina · doi:10.1016/j.oret.2022.03.024 · Cited by 23
Self-citationEspinosa‐Heidmann, D. G., Malek, G., Mettu, P. S., Caicedo, A., Saloupis, P., Gach, S., Dunnon, A. K., Hu, P., Spiga, M., & Cousins, S. W. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12546 · Cited by 23
Granstam, E., Aurell, S., Sjövall, K., & Paul, A. (2021) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-020-05059-y · Cited by 23
Massougnes, S. D., Dirani, A., & Mantel, I. (2017) · Retina · doi:10.1097/iae.0000000000001613 · Cited by 22
Hara, C., Suzue, M., Fujimoto, S., Fukushima, Y., Sayanagi, K., Nishida, K., Maruyama, K., Sato, S., & Nishida, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020385 · Cited by 22
Compartmental Exudative Dynamics in Neovascular Age-Related Macular Degeneration
Ehlers, J. P., Lunasco, L. M., Yordi, S. F., Cetin, H., Le, T. K., Sarıcı, K., Kaiser, P. K., Khanani, A. M., Talcott, K. E., Hu, J., et al. (2024) · Ophthalmology Retina · doi:10.1016/j.oret.2024.02.010 · Cited by 22
Rezar‐Dreindl, S., Eibenberger, K., Buehl, W., Georgopoulos, M., Weigert, G., Krall, C., Dunavoelgyi, R., Schmidt-Erfurth, U. M., & Sacu, S. (2016) · Retina · doi:10.1097/iae.0000000000001264 · Cited by 22
Daniel, E., Maguire, M. G., Grunwald, J. E., Toth, C. A., Jaffe, G. J., Martin, D. F., & Ying, G. (2020) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.0437 · Cited by 22
Self-citationRyu, C. L., Alhumaid, S., Rampakakis, E., Galic, I. J., & Chen, J. C. (2015) · Retina · doi:10.1097/iae.0000000000000877 · Cited by 21
Maguire, M. G., Ying, G., Jaffe, G. J., Toth, C. A., Daniel, E., Grunwald, J. E., Martin, D. F., & Hagstrom, S. A. (2016) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2016.0669 · Cited by 21
Self-citationLeung, K. F. C., Downes, S. M., & Chong, V. N. (2018) · Vision · doi:10.3390/vision2010005 · Cited by 21
Michl, M., Liu, X., Kaider, A., Sadeghipour, A., Gerendas, B. S., & Schmidt-Erfurth, U. M. (2020) · Acta Ophthalmologica · doi:10.1111/aos.14621 · Cited by 21
Prognostic Optical Coherence Tomography Biomarkers in Neovascular Age-Related Macular Degeneration
Nawash, B. S., Ong, J., Driban, M., Hwang, J. C., Chen, J., Selvam, A., Mohan, S., & Chhablani, J. K. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093049 · Cited by 20
THE RAP STUDY, REPORT 5: REDISCOVERING MACULAR NEOVASCULARIZATION TYPE 3
Najeeb, B. H., Deák, G. G., Mylonas, G., Sacu, S., Gerendas, B. S., & Schmidt-Erfurth, U. M. (2021) · Retina · doi:10.1097/iae.0000000000003330 · Cited by 19
Michl, M., Neschi, M., Kaider, A., Hatz, K. B., Deák, G. G., Gerendas, B. S., & Schmidt-Erfurth, U. M. (2022) · Eye · doi:10.1038/s41433-022-02376-w · Cited by 18
Dervenis, N., & Younis, S. (2016) · Clinical ophthalmology · doi:10.2147/opth.s106734 · Cited by 18
Lee, S. H., Kim, Y.-S., Nah, S. K., Kim, H. J., Park, H. Y., Yang, J. Y., Park, K., & Park, T. K. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.01.008 · Cited by 18
Hu, X., Waldstein, S. M., Riedl, S., Sadeghipour, A., Bogunović, H., Gerendas, B. S., Osborne, A. R., & Schmidt-Erfurth, U. M. (2019) · Retina · doi:10.1097/iae.0000000000002531 · Cited by 18
Wojciechowski, P., Wdowiak, M., Panek, M., Lunk, I., Carrasco, J., Zhang, X., Wu, O., Korobelnik, J.-F., & Lanzetta, P. (2025) · Ophthalmology and Therapy · doi:10.1007/s40123-025-01098-y · Cited by 17
Sadda, S., Sarraf, D., Khanani, A. M., Tadayoni, R., Chang, A., Saffar, I., Gedif, K., & Wong, D. T. (2023) · British Journal of Ophthalmology · doi:10.1136/bjo-2023-323577 · Cited by 17
GCN-assisted attention-guided UNet for automated retinal OCT segmentation
Oh, D., Moon, J. E., Park, K.-T., Kim, W., Yoo, S., Lee, H., & Yoo, J. H. (2024) · Expert Systems with Applications · doi:10.1016/j.eswa.2024.123620 · Cited by 17
Balikova, I., Postelmans, L. D., Pasteels, B., Coquelet, P., Catherine, J., Efendic, A., Hosoda, Y., Miyake, M., Yamashiro, K., ANGEL study group members, et al. (2019) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2019-000273 · Cited by 17
Bilateral Neovascular Age-Related Macular Degeneration: Comparisons between First and Second Eyes
Chew, J., Zhu, M., Broadhead, G., Luo, K., Hong, T., & Chang, A. (2017) · Ophthalmologica · doi:10.1159/000469652 · Cited by 16
Kim, K. T., Chae, J. B., Lee, S., Seo, E. J., & Kim, D. Y. (2021) · BMC Ophthalmology · doi:10.1186/s12886-021-02063-6 · Cited by 16
Ren, C., Shi, H., Jiang, J., Liu, Q., Du, Y., He, M., Cai, W., Wei, Q., & Yu, J. (2017) · Journal of Ophthalmology · doi:10.1155/2017/6145651 · Cited by 16
IMPACT OF RETINAL FLUID-FREE MONTHS ON OUTCOMES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Eichenbaum, D. A., Brown, D. M., Ip, M. S., Khanani, A. M., Figueroa, M. S., McAllister, I. L., Laude, A., Guruprasad, B., Tang, S., Gmeiner, B., et al. (2023) · Retina · doi:10.1097/iae.0000000000003699 · Cited by 15
Hussein, Z. R., Omar, S. K., Alkazraji, R. A. M., Alsamarrai, A. N., Alrubaye, H. S., & Al-Hussaniy, H. A. (2023) · Journal of Medicine and Life · doi:10.25122/jml-2022-0356 · Cited by 15
Holland, R., Kaye, R. A., Hagag, A. M., Leingang, O., Taylor, T. R. P., Bogunović, H., Schmidt-Erfurth, U., Scholl, H., Rueckert, D., Lotery, A., et al. (2024) · Ophthalmology Science · doi:10.1016/j.xops.2024.100543 · Cited by 19
Wong, D. T., Berger, A. R., Bourgault, S., Chen, J. L., Colleaux, K. M., Cruess, A. F., Dookeran, R. I., Gauthier, D., Hurley, B. R., Kapusta, M. A., et al. (2021) · Ophthalmologica · doi:10.1159/000516108 · Cited by 14
Shah, N., Maguire, M. G., Martin, D. F., Shaffer, J., Ying, G., Grunwald, J. E., Toth, C. A., Jaffe, G. J., & Daniel, E. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.11.030 · Cited by 14
Self-citationSharma, S., Sharma, T., Prasad, S. D., Gopalakrishnan, M., & Chaturvedi, A. (2021) · Ophthalmology and Therapy · doi:10.1007/s40123-021-00362-1 · Cited by 13
Zandi, S., Weisskopf, F., Garweg, J. G., Pfister, I. B., Prünte, C. F., Sutter, F., & Hatz, K. B. (2017) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20170329-07 · Cited by 13
Esen, F., Alhan, Ö., Bektaşoğlu, P. K., & Şahin, Ö. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.06.019 · Cited by 13
Lee, S., Kim, K. T., Kim, D. Y., Chae, J. B., & Seo, E. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-32184-5 · Cited by 12
Heloterä, H., Siintamo, L., Kivinen, N., Abrahamsson, N., Aaltonen, V., & Kaarniranta, K. (2024) · Acta Ophthalmologica · doi:10.1111/aos.16681 · Cited by 12
Aziz, A. A., Khanani, A. M., Khan, H., Lauer, E., Khanani, I., Mojumder, O., Khanani, Z. A., Khan, H., Gahn, G. M., Graff, J. T., et al. (2024) · Eye · doi:10.1038/s41433-024-03532-0 · Cited by 12
Haji, H., Gianniou, C., Brynskov, T., Sørensen, T. L., Olsen, R. H., & Nielsen, M. K. (2022) · Acta Ophthalmologica · doi:10.1111/aos.15233 · Cited by 12
Scott, I. U., Oden, N. L., VanVeldhuisen, P., Ip, M. S., & Blodi, B. A. (2023) · Ophthalmology · doi:10.1016/j.ophtha.2023.05.023 · Cited by 12
Cho, H. J., Yoon, W., Yoon, J., Na, S. K., Lee, J., Kim, J., Kim, C. G., & Kim, J. W. (2021) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2021.07.026 · Cited by 12
Takasago, Y., Shiragami, C., Kobayashi, M., Osaka, R., Ono, A., Yamashita, A., Tsujikawa, A., & Hirooka, K. (2017) · Retina · doi:10.1097/iae.0000000000001980 · Cited by 11
Cho, H. J., Song, M. Y., Yoon, W., Yoon, J., Na, S. K., Lee, J., Kim, J., & Kim, J. W. (2022) · Scientific Reports · doi:10.1038/s41598-022-07108-4 · Cited by 11
Dirani, A., & Mantel, I. (2018) · Clinical ophthalmology · doi:10.2147/opth.s160367 · Cited by 11
In vivo monitoring of active subretinal fibrosis in mice using collagen hybridizing peptides
Linder, M., Bennink, L. L., Foxton, R. H., Kirkness, M. W. H., & Westenskow, P. D. (2024) · Lab Animal · doi:10.1038/s41684-024-01408-0 · Cited by 9
New Directions for Ophthalmic OCT – Handhelds, Surgery, and Robotics
Foust, J. S., McCloud, M., Narawane, A. M., Trout, R. M., Chen, X., Dhalla, A.-H. Z., Li, J. D., Viehland, C., Draelos, M., Vajzovic, L. M., et al. (2025) · Translational Vision Science & Technology · doi:10.1167/tvst.14.1.14 · Cited by 11
Self-citationYap, D. W. T., Tan, B. K. J., Teo, K. Y. C., Wong, T. Y., & Cheung, C. M. G. (2025) · Ophthalmology Retina · doi:10.1016/j.oret.2025.01.010 · Cited by 11
Gabrielle, P., Nguyen, V., Arnold, J., Bhandari, S., Viola, F., Tigchelaar-Besling, O. A. M., Garay‐Aramburu, G., O’Toole, L., Cheung, C. M. G., Barthelmes, D., et al. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.13.5 · Cited by 10
Varnousfaderani, E. S., Wu, J., Vogl, W., Philip, A.-M., Montuoro, A., Leitner, R., Simader, C., Waldstein, S. M., Gerendas, B. S., & Schmidt-Erfurth, U. M. (2016) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2016.03.012 · Cited by 10
Toth, C. A., Tai, V., Chiu, S. J., Winter, K. P., Sevilla, M. B., Daniel, E., Grunwald, J. E., Jaffe, G. J., Martin, D. F., Ying, G., et al. (2017) · Ophthalmology Retina · doi:10.1016/j.oret.2017.09.016 · Cited by 10
Self-citationVujosevic, S., Toma, C., Sarao, V., Veritti, D., Brambilla, M., Muraca, A., Cillà, S. D., Villani, E., Nucci, P., & Lanzetta, P. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.2.33 · Cited by 10
Lee, A., Garg, P. G., Lyon, A. T., Mirza, R. G., & Gill, M. K. (2020) · Journal of Ophthalmic and Vision Research · doi:10.18502/jovr.v15i3.7452 · Cited by 11
Sharma, S., & Ma, K. (2018) · International Journal of Ophthalmology & Eye Science · doi:10.19070/2332-290x-1800074 · Cited by 9
Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert Opinion
Balaskas, K., Amoaku, W. M. K., Cudrnak, T., Downey, L., Groppe, M., Mahmood, S., Mehta, H., Mohamed, Q. A., Mushtaq, B., Severn, P. S., et al. (2021) · Ophthalmology and Therapy · doi:10.1007/s40123-021-00342-5 · Cited by 10
Chaudhary, V., Chair, R. E. T. I. A. (. E. T. I. N. A. ). S. G., Bhandari, M., Wykoff, C. C., Sivaprasad, S., Thabane, L., Kaiser, P. K., Sarraf, D., Bakri, S. J., Garg, S. J., et al. (2022) · Eye · doi:10.1038/s41433-022-02221-0 · Cited by 9
Salehi, M. A., Frounchi, N., Zakavi, S. S., Mohammadi, S., Harandi, H., Shojaei, S., Gouravani, M., & Arévalo, J. F. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.04.001 · Cited by 9
Ohayon, A., Rosa, I. D., Semoun, O., Jung, C., Colantuono, D., Ameen, A. E., Srour, M., & Souied, E. H. (2019) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2019-314923 · Cited by 9
Vofo, B. N., Beykin, G., Levy, J., & Chowers, I. (2021) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2021-319054 · Cited by 10
Gadiollet, E., Kodjikian, L., Vasson, F., Kodaday, K., Chirpaz, N., Wolff, B., Bats, F. D., Feldman, A., Pradat, P., Gascon, P., et al. (2024) · Eye · doi:10.1038/s41433-024-03256-1 · Cited by 8
Lenhof, S., Kodjikian, L., Gascon, P., Gadiollet, E., Feldman, A., Bats, F. D., Wolff, B., Pradat, P., & Mathis, T. (2024) · Acta Ophthalmologica · doi:10.1111/aos.16759 · Cited by 8
Kim, J. H., Kim, J. W., & Kim, C. G. (2022) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2021.0103 · Cited by 8
Xue, K., Hua, P., Maguire, M. G., Daniel, E., Jaffe, G. J., Grunwald, J. E., Ying, G., Williams, D. F., Beardsley, S., Bennett, S. R., et al. (2023) · Ophthalmology Retina · doi:10.1016/j.oret.2023.02.008 · Cited by 9
Self-citationMichalewska, Z., Michalewski, J., Nawrocki, J., & Izdebski, B. (2014) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.133485 · Cited by 8
Sharma, S., & Ma, K. (2018) · International Journal of Ophthalmology & Eye Science · doi:10.19070/2332-290x-1800076 · Cited by 8
Zhao, Z. Y., Yang, F., Gong, Y., Yu, S., Liu, H., Wang, H., Wang, F., & Sun, X. (2019) · Ophthalmologica · doi:10.1159/000497491 · Cited by 8
Retinal pigment epithelial characteristics in eyes with neovascular age-related macular degeneration
Ebner, C., Wernigg, C., Schütze, C., Weingessel, B., & Vécsei‐Marlovits, P. V. (2020) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01718-6 · Cited by 8
Deep Learning–Based Retinal Nerve Fiber Layer Thickness Measurement of Murine Eyes
Ma, R., Liu, Y., Tao, Y., Alawa, K. A., Shyu, M., & Lee, R. K. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.8.21 · Cited by 8
Book, M., Ziegler, M., Rothaus, K., Faatz, H., Gutfleisch, M., Spital, G., Lommatzsch, A. P., & Pauleikhoff, D. (2021) · Der Ophthalmologe · doi:10.1007/s00347-021-01474-6 · Cited by 8
Song, Y.-Y., Jun, J., Kim, J., Lee, S.-C., & Lee, M. (2022) · Retina · doi:10.1097/iae.0000000000003628 · Cited by 8
Narayan, D. S., & Muecke, J. S. (2015) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.171964 · Cited by 8
Vogel, R. N., Davis, D. B., Kimura, B. H., Rathinavelu, S., Graves, G. S., Szabó, A., & Han, D. P. (2016) · Retina · doi:10.1097/iae.0000000000001150 · Cited by 8
Maruyama-Inoue, M., Sato, S., Yamane, S., & Kadonosono, K. (2019) · Clinical ophthalmology · doi:10.2147/opth.s224319 · Cited by 8
İnan, S., Polat, O., Karadaş, M., & İnan, Ü. U. (2019) · Romanian Journal of Ophthalmology · doi:10.22336/rjo.2019.36 · Cited by 8
Hosseini, H., Rabina, G., Pettenkofer, M. S., Au, A. C., Chehaibou, I., Heilweil, G., Weiner, A. J., Ip, M. S., Loewenstein, A., & Schwartz, S. D. (2020) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-020-05024-9 · Cited by 8
Bhatia, B., Sim, S. Y., Chalkiadaki, E., Koutsocheras, G., Nicholson, L., Selvam, S., Sivaprasad, S., Pal, B., Huemer, J. C., Keane, P. A., et al. (2025) · Ophthalmology and Therapy · doi:10.1007/s40123-025-01108-z · Cited by 7
William, A., Blak, M. D., Eshref, A., Gekeler, F., Schatz, A., & Gekeler, K. (2022) · Clinical ophthalmology · doi:10.2147/opth.s346291 · Cited by 7
Arnon, R., Pikkel, J., Yahalomi, T., Stanescu, N., Wood, K., Leshno, A., Achiron, A., & Hilely, A. (2022) · International Ophthalmology · doi:10.1007/s10792-022-02337-y · Cited by 7
Ocular pulse amplitude and retinal vessel caliber changes after intravitreal ranibizumab
Pekel, G., Acer, S., Çetin, E. N., Yağcı, R., Kaşıkçı, A., & Çevik, A. (2014) · International Ophthalmology · doi:10.1007/s10792-014-9991-z · Cited by 8
Fu, H., Zhang, B., Tong, J., Bedell, H. E., Zhang, H., Yang, Y., Nie, C., Luo, Y., & Liu, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185070 · Cited by 8
Kim, K. T., Lee, H., Kim, J. Y., Lee, S., Chae, J. B., & Kim, D. Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061863 · Cited by 7
Chong Teo, K. Y., Nguyen, V., Gemmy Cheung, C. M., Arnold, J., Chen, F. K., Barthelmes, D., & Gillies, M. C. (2021) · Zurich Open Repository and Archive (University of Zurich) · doi:10.1097/iae.0000000000003267 · Cited by 6
Cavalleri, M., Tombolini, B., Sacconi, R., Gatta, G., Valeri, R., Bandello, F. M., & Querques, G. (2023) · Ophthalmologica · doi:10.1159/000530544 · Cited by 6
Nguyen, V., Puzo, M., Sánchez‐Monroy, J., Gabrielle, P., Creuzot-Garcher, C. P., Baudin, F., Wolff, B., Castelnovo, L., Michel, G., O’Toole, L., et al. (2020) · Retina · doi:10.1097/iae.0000000000003061 · Cited by 6
Detaram, H. D., Liew, G., Russell, J. C., Vu, K. V., Burlutsky, G., Mitchell, P. L. R., & Gopinath, B. (2020) · Acta Ophthalmologica · doi:10.1111/aos.14394 · Cited by 6
Razavi, H., Arnold, J., & Guymer, R. H. (2015) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12658 · Cited by 6
Gnanaraj, R., Lisker-Cervantes, A., Patnaik, J. L., Rajeswaren, V., Mehta, N. B., Gange, W. S., Lynch, A. M., Palestine, A. G., Mathias, M., Manoharan, N., et al. (2025) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2024-002112 · Cited by 5
A Delphi study on the clinical management of age-related macular degeneration
Gomes, N., Meireles, A., Carneiro, Â. M., da Silva, R. M., Campos, A., Duarte, L., Flores, R., Marques‐Neves, C., On behalf of the Portuguese RAMD consensus group, de Abreu, C. C. B., et al. (2022) · International Ophthalmology · doi:10.1007/s10792-021-02177-2 · Cited by 5
Thottarath, S., Gurudas, S., Chandak, S., Patel, P. J., Kotagiri, A. K., Pearce, I., McKibbin, M., Menon, G., Burton, B., Talks, J. S., et al. (2024) · Eye · doi:10.1038/s41433-024-03110-4 · Cited by 5
van Romunde, S. H. M., Polito, A., Deiro, A. P., Bertazzi, L., Guerriero, M., & Pertile, G. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13880 · Cited by 5
Monés, J., Biarnés, M., & The Macbeth Study Group (2019) · European Journal of Ophthalmology · doi:10.1177/1120672119848961 · Cited by 5
Lee, H., Jang, M., Kim, H. C., & Chung, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-56420-z · Cited by 5
Age-Related Macular Degeneration
Hellman, J. B., & Yiu, G. C. (2018) · Current practices in ophthalmology · doi:10.1007/978-981-10-8545-1_2 · Cited by 5
Li, X., Luo, H., Zuo, C., Zhang, Z., Zhang, J., & Zhang, M. (2018) · Retina · doi:10.1097/iae.0000000000002152 · Cited by 5
Best Clinical Practice for Age-Related Macular Degeneration Imaging
Freund, K. B., Toth, C. A., & Zarbin, M. A. (2019) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126419834702 · Cited by 5
Self-citationArtificial intelligence in individualized retinal disease management
Zhang, Z., & Li, J. (2024) · International Journal of Ophthalmology · doi:10.18240/ijo.2024.08.19 · Cited by 4
Yanai, R., Murao, F., Miki, A., Terasaki, H., Chujo, S., Sakaeda, Y., Seki, K., Ishigooka, G., Iwase, T., Ohara, H., et al. (2025) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2025-002415 · Cited by 4
Makarczyk, L. D. S. Q., Ugarte, M. D. F. S., Vieira, B. V., Kniggendorf, S. L., & Regatieri, C. V. (2020) · International Journal of Retina and Vitreous · doi:10.1186/s40942-020-00212-5 · Cited by 4
Sutter, D., Anderson, A., Wheatley, S., & Sheth, V. S. (2024) · Cureus · doi:10.7759/cureus.56652 · Cited by 4
Khanani, A. M., Sadda, S. R., Sarraf, D., Tadayoni, R., Wong, D. T., Kempf, A.-S., Saffar, I., Gedif, K., & Chang, A. (2024) · Ophthalmology Retina · doi:10.1016/j.oret.2024.07.012 · Cited by 4
Metadata
- Authors
- Jaffe, G. J., Martin, D. F., Toth, C. A., Daniel, E., Maguire, M. G., Ying, G.-S., Grunwald, J. E., & Huang, J.
- Affiliations
- Duke University (US)
- Cleveland Clinic (US)
- University of Pennsylvania (US)
- Corresponding author
- Jaffe, Glenn J.
- ORCID
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 120
- Issue
- 9
- Pages
- 1860-1870
- ISSN
- 0161-6420 (ISSN-L)
- PMC
- PMC3737287
- OpenAlex
- W2074575505
- Cited by
- 294
- References
- 15
- Citations by year
- 2026: 9 · 2025: 28 · 2024: 26 · 2023: 16 · 2022: 29 · 2021: 38 · 2020: 27 · 2019: 21 · 2018: 23 · 2017: 24 · 2016: 17 · 2015: 15 · 2014: 15 · 2013: 5
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Eye Institute (U10EY017825, U10EY017826, U10EY017823, U10EY017828)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- neovascular age-related macular degeneration, ranibizumab, bevacizumab, anti-VEGF therapy, macular morphology, visual acuity, intraretinal fluid, subretinal fluid, retinal thickness, lesion activity, macular edema
- MeSH terms
- Bevacizumab, Ranibizumab, Fluorescein Angiography, Follow-Up Studies, Humans, Macula Lutea, Macular Degeneration, Prospective Studies, Visual Acuity, Angiogenesis Inhibitors, Tomography, Optical Coherence, Vascular Endothelial Growth Factor A, Subretinal Fluid, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
